Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group.
Smith LM, Anderson JR, Qualman SJ, Crist WM, Paidas CN, Teot LA, Pappo AS, Link MP, Grier HE, Wiener ES, Breneman JC, Raney RB, Maurer HM, Donaldson SS. Smith LM, et al. Among authors: teot la. J Clin Oncol. 2001 Oct 15;19(20):4058-64. doi: 10.1200/JCO.2001.19.20.4058. J Clin Oncol. 2001. PMID: 11600608
Routine brain imaging is unwarranted in asymptomatic patients with rhabdomyosarcoma arising outside of the head and neck region that is metastatic at diagnosis: a report from the Intergroup Rhabdomyosarcoma Study Group.
Spunt SL, Anderson JR, Teot LA, Breneman JC, Meyer WH, Pappo AS; Intergroup Rhabdomyosarcoma Study Group. Spunt SL, et al. Among authors: teot la. Cancer. 2001 Jul 1;92(1):121-5. doi: 10.1002/1097-0142(20010701)92:1<121::aid-cncr1299>3.0.co;2-d. Cancer. 2001. PMID: 11443617
Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Breitfeld PP, Lyden E, Raney RB, Teot LA, Wharam M, Lobe T, Crist WM, Maurer HM, Donaldson SS, Ruymann FB. Breitfeld PP, et al. Among authors: teot la. J Pediatr Hematol Oncol. 2001 May;23(4):225-33. doi: 10.1097/00043426-200105000-00010. J Pediatr Hematol Oncol. 2001. PMID: 11846301 Clinical Trial.
Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
Chiles MC, Parham DM, Qualman SJ, Teot LA, Bridge JA, Ullrich F, Barr FG, Meyer WH; Soft Tissue Sarcoma Committee of the Children's Oncology Group. Chiles MC, et al. Among authors: teot la. Pediatr Dev Pathol. 2004 Nov-Dec;7(6):583-94. doi: 10.1007/s10024-004-5058-x. Epub 2004 Nov 17. Pediatr Dev Pathol. 2004. PMID: 15630526
Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group.
Chiles MC, Parham DM, Qualman SJ, Teot LA, Bridge JA, Ullrich F, Barr FG, Meyer WH; Soft Tissue Sarcoma Committee of Children's Oncology Group. Chiles MC, et al. Among authors: teot la. Pediatr Dev Pathol. 2005 Jan-Feb;8(1):141. doi: 10.1007/s10024-005-1550-1. Pediatr Dev Pathol. 2005. PMID: 15803220 No abstract available.
106 results